The Changing Environment Around Accelerated Approvals and Regulatory Pathways
PharmaTalkRadio7 Okt 2022

The Changing Environment Around Accelerated Approvals and Regulatory Pathways

In this session recorded at CMO Summit 2022, panelists share strategy trends and opportunities around accelerated approvals and regulatory designations. Additionally, they discuss: How to approach the FDA based on the different types of meetingsHow these trends and pathways affect trial designImplications after approval based on the pathway Speakers: Edith Perez, MD, CMO, Bolt BiotherapeuticsJeffrey Bornstein, MD, CMO, Eledon PharmaceuticalsAmy Blawas, PhD, Principal Consultant, NDA Group

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
rss-ufobortom-rimligt-tvivel
medicinvetarna
rss-vetenskapsradion
det-morka-psyket
svd-nyhetsartiklar
rss-spraket
sexet
halsorevolutionen
paranormalt-med-caroline-giertz
rss-vetenskapsradion-2
rss-odla
vetenskapsradion
dumforklarat
hacka-livet
rss-italiensk-dagbok
rss-ronden